Bill > A06709

This bill establishes new requirements for medical cannabis practitioners and creates an endocannabinoid system awareness program. Specifically, practitioners who want to certify patients for medical cannabis must now complete a two-hour course that covers comprehensive topics including cannabis pharmacology, potential side effects, drug interactions, dosing, administration routes, risks and benefits, and abuse prevention. The bill also mandates the creation of an endocannabinoid system awareness program within the department of health, which will provide educational resources to healthcare practitioners about how the endocannabinoid system interacts with other bodily systems. The program will cover topics such as the endocannabinoid system's relationship to chronic pain, opioids, pharmacogenetics, FDA-approved cannabinoid medications, cannabis consumption impacts, and medication interactions. Both the office of cannabis management and the department of health are required to publish information about this program on their respective websites. The bill will take effect 180 days after becoming law, with immediate authorization for developing necessary regulations.

Health and Social Services

https://www.nysenate.gov/legislation/bills/2025/A6709